TD Cowen: 'Edwards Lifesciences (EW) Share Gain Story Includes TAVR and TMTT Chapters'
Tweet Send to a Friend
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $97.00 price target on Edwards Lifesciences (NYSE: EW).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
